Nimotuzumab

A4DAB179 | Cancer | Approved
EGFR/ERBB1/HER1
G1 / IgG1
Biocon Biopharmaceuticals Biotech Pharmaceutical Center of Molecular Immunology CIMYM Daiichi Sankyo Inc Eurofarma Gilead Sciences Innogene Kalbiotech InnoMab Kuhnil Pharmaceutical Company Laboratorios Pisa Oncoscience
Approved
Whole mAb
DE-766 DE766 DE 766 KI-0501 KI0501 KI 0501 KI-501 KI 501 KI501 KI-0502 KI0502 KI 0502 KI-502 KI502 KI 502 OSAG101 OSAG-101 OSAG 101 Taixinsheng TheraCIM Theraloc VECTHIX
—
IMGT PubChem (135356483) PubChem (160698394) PubChem (249565669) PubChem (349341271) PubChem (404770141) PubChem (461629175) PubChem (463565368) PubChem (472402092) PubChem (486348040) PubChem (488222554) PubChem (498127495) PubChem (505186985) PubChem (505850081) Thera-SAbDab YAbS
Avg A4D Score
-0.7451
Score Range
-0.75
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB179_3gkw_H_L 3gkw 100% -0.7451 6.5 4.0 -0.5245 -0.7801